BIOMAT Database Logo BIOMAT Database Logo

Effect of oral hypoglycaemic drugs on glucose tolerance and insulin secretion in borderline diabetic patients. 1978

L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.
January 1980, Current medical research and opinion,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Effect of oral hypoglycaemic agents on glucose tolerance in pancreatic diabetes.
April 1972, Gut,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
[Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients].
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion.
July 1991, Obstetrics and gynecology,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients.
January 1984, Diabetes care,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.
November 1991, Diabetes care,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Effect of age on intravenous glucose tolerance and insulin secretion.
January 1976, Journal of the American Geriatrics Society,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Effect of sham-feeding on glucose tolerance and insulin secretion.
May 1987, Acta endocrinologica,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment.
January 1989, European journal of clinical pharmacology,
L Papoz, and D Job, and E Eschwege, and J P Aboulker, and J Cubeau, and G Pequignot, and M Rathery, and G Rosselin
[Insulin secretion in subclinical diabetes following oral glucose tolerance].
January 1974, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!